Overview
What is Mucuna pruriens?
What are Mucuna pruriens’ main benefits?
What are Mucuna pruriens’ main drawbacks?
How does Mucuna pruriens work?
Dosage information
Most trials looking at the effects of Mucuna pruriens on symptoms of Parkinson's disease or male infertility have used daily doses ranging between 5 and 45 grams of adequately prepared seed powder, corresponding to approximately 200 mg to 1,500 mg of L-DOPA.
Preparations of Mucuna pruriens, which contain L-DOPA, may be 2–3 times more potent than an equivalent dose of isolated L-DOPA (when not combined with carbidopa). Mucuna pruriens should not be used in conjunction with medications containing L-DOPA; combining the two could potentially result in excessively high dopamine levels, leading to adverse effects. Also, the potential blood-glucose-lowering properties of Mucuna pruriens mean that it could interact with diabetes medications.
Frequently asked questions
Is Mucuna pruriens edible?
What is the nutritional profile of Mucuna pruriens?
Does Mucuna pruriens have antidiabetic properties?
Is Mucuna pruriens superior to isolated L-DOPA?
What are other names for Mucuna Pruriens?
Update History
Big update with new FAQs
References
Examine Database References
- Parkinson's Disease Symptoms - Roberto Cilia, Janeth Laguna, Erica Cassani, Emanuele Cereda, Benedetta Raspini, Michela Barichella, Gianni PezzoliDaily intake of Mucuna pruriens in advanced Parkinson's disease: A 16-week, noninferiority, randomized, crossover, pilot studyParkinsonism Relat Disord.(2018 Apr)
- Parkinson's Disease Symptoms - Roberto Cilia, Janeth Laguna, Erica Cassani, Emanuele Cereda, Nicolò G Pozzi, Ioannis U Isaias, Manuela Contin, Michela Barichella, Gianni PezzoliMucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover studyNeurology.(2017 Aug 1)
- Parkinson's Disease Symptoms - Katzenschlager R, Evans A, Manson A, Patsalos PN, Ratnaraj N, Watt H, Timmermann L, Van der Giessen R, Lees AJMucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological studyJ Neurol Neurosurg Psychiatry.(2004 Dec)